Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein SA pseudogene 72 (RPSAP72) is part of the multicopy pseudogene family related to ribosomal protein SA (RPSA), a protein implicated as a cell surface laminin receptor and ribosomal component. Pseudogenes such as RPSAP72 do not encode functional proteins and generally lack biological activity. While some pseudogenes may be transcribed and have minor regulatory roles as non-coding RNAs, no specific function, disease relevance, or therapeutic targeting has been described for RPSAP72. The canonical drug target in clinical and molecular studies is ribosomal protein SA (RPSA), not its pseudogenes.
None. Pseudogenes lack an active role in mechanisms of action for drugs.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein SA pseudogene 72 (RPSAP72).